Dysesthesia associated with GLP-1 agonist therapies: data-mining analysis and literature review
For those under Medicare, Medicaid, or commercial insurance, Klinic manages the verification process ahead of your first appointment, eliminating financial surprises
Authors: Karen G Farrar University of Southern California , Los Angeles, CA, Duy Do Truveta, Inc , Bellevue, WA, Nina B Masters Truveta, Inc , Bellevue, WA, Brianna M Cartwright Truveta, Inc , Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred formulary option in July 2025, switching from anti-obesity tirzepatide surged from 0.6% to 9.7%, representing more than a 16-fold rise
Due to the patients inability to keep down oral antibiotics, she was admitted to the inpatient service